Skip to content
Review

A systematic review and meta-analysis comparing the clinical outcomes of the Watchman FLX versus Watchman 2.5 device for transcatheter left atrial appendage occlusion in patients with atrial fibrillation.

Jul 2026 · Critical Pathways in Cardiology · 0 citations
Medicine

TL;DR

The Watchman FLX is associated with significantly superior safety and efficacy outcomes relative to the Watchman 2.5 across the principal clinical domains of transcatheter LAAO.

View source

Similar papers

Open access Aug 2026

Left atrial appendage closure versus medical therapy in atrial fibrillation: An updated meta-analysis of randomized trials on the trade-off between stroke prevention and bleeding.

LAAC provides thromboembolic protection comparable to medical therapy while reducing non-procedural bleeding, and its role as an alternative strategy in selected patients at increased bleeding risk is supported.

G. Di Pietro, Riccardo Improta, E. Bruno et al. · 0 citations
Review Sep 2026

One-Year Outcomes of Myval Versus Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: A Systematic Review and Meta-Analysis.

Myval demonstrated comparable all-cause mortality, cardiovascular death, stroke, and PPI rates to contemporary THVs at 1 year, along with favorable hemodynamics versus SAPIEN, supporting Myval as an effective contemporary TAVI platform; longer-term studies are needed to confirm durability and clinical outcomes.

Faisal A. Al-Harbi, Ahmad K. Alanazi, N. Algoblan et al. · 0 citations
Review Sep 2026

Clinical Outcomes of Conduction System versus Right Ventricular Pacing after TAVR: A Systematic Review and Meta-Analysis.

The potential clinical relevance of CSP when a high ventricular pacing burden is anticipated remains plausible but was not directly demonstrated by the available data; adequately powered randomized trials are required before routine adoption.

R. Shakeel, A. Uddin, D. Ladhani et al. · 0 citations
Review Aug 2026

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-analysis.

BACKGROUND Stroke prevention after transcatheter aortic valve replacement (TAVR) in patients with atrial fibrillation remains clinically challenging because thromboembolic risk must be balanced against substantial bleeding vulnerability. Left atrial appendage occlusion (LAAO) has been proposed as a nonpharmacologic alt...

Mustafa Abomohsen, Amr Elboliney, A. Mohamed et al. · 0 citations
Review Open access Aug 2026

“Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials”

LAAC provides similar overall efficacy and safety compared with medical therapy for stroke prevention in AF but should currently remain reserved for selected patients rather than replacing oral anticoagulation broadly, indicating current evidence remains underpowered and additional randomized trials are needed.

A. AL-Janabi, A. Al-shammari, A. Hageen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.